• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Digital Health VC Funding Hits $2 Billion in Q1 2019, Reports Mercom Capital Group

Share:

April 22, 2019

Mercom Capital Group, llc, a global communications and research firm, released its report on funding and merger and acquisition activity for the Digital Health sector for the first quarter of 2019. Mercom’s report covers deals of all sizes from across the globe.

Venture capital funding, including private equity and corporate venture capital into Digital Health companies in Q1 2019, came to $2 billion (B) in 149 deals versus $1.4B in 142 deals in Q4 2018. VC funding in Q1 2019 fell 19% versus in Q1 2018 when nearly $2.5B was raised in 187 deals.

Since 2010, Digital Health companies raised ~ $37B in VC funding.

Total corporate funding for Digital Health companies – including VC, debt, and public market financing – totaled $2.2B in Q1 2019.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“Funding levels were down versus last year in Digital Health in the absence of larger deals. M&A activity was also flat. However, Digital Health public equities experienced a turnaround in Q1 with 66% of them beating the S&P 500 versus Q4 2018 when 63% of the equities we tracked performed below the S&P 500. Favorable market conditions have prompted several companies to announce IPO plans,” said Raj Prabhu, CEO of Mercom Capital Group.

Top funded categories in Q1 2019 included: $557M raised by Data Analytics companies, mHealth Apps with $392M, Telemedicine with $220M, Healthcare Booking with $177M, Clinical Decision Support with $107M, Mobile Wireless with $90M and $80M for Healthcare IT Service Providers.

There were 48 early-round deals in Q1 2019.

The top VC deals in Q1 2019 included: $170M raised by Doctolib, $100M from Health Catalyst, $88M raised by Calm, and $80M by Taimei Medical Technology.

A total of 371 investors participated in funding deals in Q1 2019 versus 412 investors in Q1 2018. There were 16 FDA and CE approvals issued to Digital Health companies in Q1 2019.

Digital Health VC funding deals were distributed across 17 countries in Q1 2019.

In Q1 2019, there were 45 M&A transactions involving Digital Health companies versus 48 M&A transactions in Q1 2018.

The top disclosed M&A transaction in Q1 2019 was the $195M acquisition of Voalte by Hill-Rom Holdings.

Date: April 22, 2019

Source: BusinessWire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Biodesix Partners with Streck to Support in Vitro Diagnostic (IVD) StrategyBiodesix Partners with Streck to Support in Vitro Diagnostic (IVD) Strategy
  • Luciole Medical AG Announces the Acquisition of Spiegelberg GmbH & Co. KG to Create a Leading Global Brain Monitoring Developer and ProviderLuciole Medical AG Announces the Acquisition of Spiegelberg GmbH & Co. KG to Create a Leading Global Brain Monitoring Developer and Provider
  • Amulet Capital’s OPEN Health Merges with Pharmerit InternationalAmulet Capital’s OPEN Health Merges with Pharmerit International
  • Chemistree Acquires Global Rights to Sugarleaf Brand, Enters California MarketChemistree Acquires Global Rights to Sugarleaf Brand, Enters California Market
  • Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine ImplantsJohnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH to Enhance Global Offering of Interbody Spine Implants
  • Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all the Scilex Common Shares, Preferred Shares, and Warrants Owned by Sorrento Therapeutics, Inc.Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all the Scilex Common Shares, Preferred Shares, and Warrants Owned by Sorrento Therapeutics, Inc.
  • Roche launches 2 lab management apps under its Viewics platformRoche launches 2 lab management apps under its Viewics platform
  • Merit acquires Cianna and announces multimillion-dollar investmentMerit acquires Cianna and announces multimillion-dollar investment

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications